» Authors » Nathan Herrmann

Nathan Herrmann

Explore the profile of Nathan Herrmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 439
Citations 11210
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sankhe K, Tumati S, Perin J, Rivet L, Vieira D, Rosenberg P, et al.
Int Psychogeriatr . 2025 Mar; 37(2):100012. PMID: 40086910
Background: Previous trials have shown improvements in both apathy and cognition with methylphenidate (MPH). Objectives: To assess whether changes in apathy correlated with changes in cognition in the Apathy in...
2.
Hatch S, Seitz D, Bruneau M, Ewa V, Feldman S, Goldberg Y, et al.
Can Geriatr J . 2025 Mar; 28(1):91-102. PMID: 40051590
In Canada, approximately 730,000 people are currently living with dementia. Over 75% will experience behavioural and psychological symptoms of dementia (BPSD). There is a lack of consensus on best practices...
3.
Song B, Jiang G, Wong M, Gallagher D, MacIntosh B, Andreazza A, et al.
J Neurophysiol . 2025 Feb; 133(3):924-929. PMID: 39951673
Angiogenesis may play an important role in the pathophysiology of Alzheimer's disease (AD). Previous in vitro and in vivo studies suggest a link between angiogenesis and cerebral blood flow (CBF)...
4.
Coleman K, Berry S, Cummings J, Hsiung G, Laforce R, Huey E, et al.
Lancet Neurol . 2025 Jan; 24(2):128-139. PMID: 39862881
Background: No treatments exist for apathy in people with frontotemporal dementia. Previously, in a randomised double-blind, placebo-controlled, dose-finding study, intranasal oxytocin administration in people with frontotemporal dementia improved apathy ratings...
5.
Chertkow H, Phillips N, Rockwood K, Anderson N, Andrew M, Bartha R, et al.
J Alzheimers Dis . 2024 Dec; 102(3):535-561. PMID: 39636028
The Canadian Consortium on Neurodegeneration in Aging (CCNA) was created by the Canadian federal government through its health research funding agency, the Canadian Institutes for Health Research (CIHR), in 2014,...
6.
Sujanthan S, Southwell A, Armel T, Xing E, Kapoor A, Liu X, et al.
Can J Neurol Sci . 2024 Nov; 1-9. PMID: 39568224
Background: The depression, obstructive sleep apnea and cognitive impairment (DOC) screen assesses three post-stroke comorbidities, but additional information may be gained from the time to complete the screen. Cognitive screening...
7.
Lin W, Yu D, Xiong L, Zebarth J, Wang R, Fischer C, et al.
Alzheimers Dement . 2024 Nov; 21(1):e14376. PMID: 39559926
Introduction: Elevated plasma homocysteine (Hcy) is associated with an increased risk of developing neurodegenerative diseases; however, its relationship with the apolipoprotein E (APOE) ε4 allele has not been well characterized....
8.
Rajji T, Bowie C, Herrmann N, Pollock B, Lanctot K, Kumar S, et al.
JAMA Psychiatry . 2024 Oct; 82(1):12-21. PMID: 39476073
Importance: Older adults with major depressive disorder (MDD) or mild cognitive impairment (MCI) are at high risk for cognitive decline. Objective: To assess the efficacy of cognitive remediation (CR) plus...
9.
Choi J, Beroncal E, Chernega T, Brooks H, Kennedy J, Fisher C, et al.
Transl Psychiatry . 2024 Oct; 14(1):457. PMID: 39468012
Mild cognitive impairment (MCI) is a prodromal stage in aging to possible progression to Alzheimer's disease and related dementia (ADRD), where co-occurrence of major depressive disorder (MDD) accelerates the progression....
10.
Tumati S, Herrmann N, Perin J, Rosenberg P, Lerner A, Mintzer J, et al.
Int Psychogeriatr . 2024 Sep; 36(12):1232-1244. PMID: 39297292
Objectives: Among participants with Alzheimer's disease (AD) we estimated the minimal clinically important difference (MCID) in apathy symptom severity on three scales. Design: Retrospective anchor- and distribution-based analyses of change...